Overview Fundamentals API Earnings EOD API Sample Code Pricing

Eagle Pharmaceuticals Inc (EGRX NASDAQ) stock market data APIs

$5.78 -0.09(-1.5%) as of July 19, 2024
Price chart is built with Anychart

Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium to treat organophosphate exposure; PEMFEXY, a ready-to-use/dilute liquid form of pemetrexed for non-small cell lung cancer and mesothelioma; EA-114 (fulvestrant) for HR+/HER- breast cancer; and Vasopressin injection, which is indicated to enhance blood pressure in adults with vasodilatory shock. The company has license and collaboration agreements with Combioxin, SA for the development and commercialization rights to CAL02, an antitoxin agent for the treatment of severe pneumonia in combination with traditional antibacterial drugs; and AOP Orphan Pharmaceuticals GmbH for the commercial rights of Landiolol, a novel therapeutic product candidate for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter. It has a strategic collaboration with Tyme Technologies, Inc. for the development of SM-88 to treat breast cancer (HR+/HER2-) and high-risk metastatic sarcomas. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.

Eagle Pharmaceuticals Inc Financial Data Overview

5.87
5.78
-
5.87
5.66
3.2101-23.52
76 065 K
6.9059
12 958 K
258 M
1.09
0.512
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'EGRX',
Type: 'Common Stock',
Name: 'Eagle Pharmaceuticals Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG005Y3XWH9',
ISIN: NULL,
CUSIP: NULL,
CIK: '827871',
EmployerIdNumber: '20-8179278',
FiscalYearEnd: 'December',
IPODate: '2014-02-12',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Eagle Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 258 M
  • EBITDA 62 327 K
  • Earnings Per Share 0.85
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Eagle Pharmaceuticals Inc Earnings via APIs

  • Latest Release 2023-12-08
  • EPS/Forecast 1.09

Get Eagle Pharmaceuticals Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com